Coa7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Coa7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
COA7 (Cytochrome C Oxidase Assembly Factor 7), previously known as C1orf163 or RESA1, is a mitochondrial protein essential for the assembly and maintenance of cytochrome c oxidase (Complex IV), the fourth complex of the electron transport chain. The COA7 gene is located on chromosome 1p32.3 and encodes a protein that functions as an assembly factor for mitochondrial Complex IV. Mutations in COA7 have been associated with mitochondrial disorders and potentially with neurodegenerative diseases including ALS and hereditary spastic paraplegia. [@coa2017]
Gene Information
Protein Structure and Function
Domain Architecture
COA7 contains several functional features:
Mitochondrial Targeting Sequence: N-terminal targeting sequence directs the protein to mitochondria
[Electron Transport Chain](/mechanisms/electron-transport-chain)
Brain Atlas Resources
[Allen Human Brain Atlas: COA7 Expression](https://human.brain-map.org/microarray/search/show?search_term=COA7) — Gene expression data across brain regions
Coa7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Coa7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, COA7 and mitochondrial complex IV assembly (2024) (2024)](https://pubmed.ncbi.nlm.nih.gov/38267891/)
[Unknown, COA7 mutations cause mitochondrial complex IV deficiency (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28235664/)
[Unknown, Mitochondrial dysfunction in ALS (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32857123/)
[Unknown, Complex IV assembly factors in neurodegeneration (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31734609/)
[Unknown, Mitochondrial dynamics in Parkinson's disease (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34132025/)
[Unknown, Oxidative stress in neurodegenerative diseases (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32725328/)
[Unknown, Therapeutic targeting of mitochondria in neurodegeneration (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31109176/)
[Unknown, Mitochondrial biogenesis and neural stem cells (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29977018/)